Kelly Shi
Stock Analyst at Jefferies
(1.14)
# 3,479
Out of 4,829 analysts
29
Total ratings
33.33%
Success rate
-10.54%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kelly Shi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SMMT Summit Therapeutics | Maintains: Buy | $31 → $44 | $23.96 | +83.64% | 1 | Apr 25, 2025 | |
| VSTM Verastem | Initiates: Buy | $15 | $7.17 | +109.21% | 1 | Apr 10, 2025 | |
| OPT Opthea | Downgrades: Underperform | $1 | $3.41 | -70.67% | 1 | Mar 25, 2025 | |
| TIL Instil Bio | Upgrades: Buy | $11 → $52 | $13.23 | +293.05% | 2 | Jan 7, 2025 | |
| FHTX Foghorn Therapeutics | Maintains: Buy | $18 → $14 | $4.20 | +233.33% | 2 | Dec 16, 2024 | |
| CNTA Centessa Pharmaceuticals | Maintains: Buy | $13 → $19 | $12.30 | +54.47% | 2 | Sep 11, 2024 | |
| ASND Ascendis Pharma | Maintains: Buy | $174 → $196 | $151.46 | +29.41% | 2 | Aug 13, 2024 | |
| ARTV Artiva Biotherapeutics | Initiates: Buy | $21 | $2.08 | +909.62% | 1 | Aug 13, 2024 | |
| SNDX Syndax Pharmaceuticals | Initiates: Buy | $37 | $10.70 | +245.79% | 1 | Jun 28, 2024 | |
| PROK ProKidney | Maintains: Buy | $15 → $6 | $0.72 | +737.17% | 2 | Jun 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $46 | $44.23 | +4.00% | 3 | May 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $81 | $58.98 | +37.33% | 1 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $20.15 | +73.70% | 1 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $36 | $1.19 | +2,925.21% | 1 | Feb 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $38.39 | -58.32% | 1 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $30.07 | +33.02% | 1 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $4.09 | +389.00% | 1 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8 | $2.07 | +286.47% | 1 | Aug 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $0.61 | +4,326.96% | 1 | Mar 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $52 | $14.21 | +265.94% | 1 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $0.81 | +3,234.16% | 1 | Apr 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $33 | $1.60 | +1,962.50% | 1 | Mar 8, 2021 |
Summit Therapeutics
Apr 25, 2025
Maintains: Buy
Price Target: $31 → $44
Current: $23.96
Upside: +83.64%
Verastem
Apr 10, 2025
Initiates: Buy
Price Target: $15
Current: $7.17
Upside: +109.21%
Opthea
Mar 25, 2025
Downgrades: Underperform
Price Target: $1
Current: $3.41
Upside: -70.67%
Instil Bio
Jan 7, 2025
Upgrades: Buy
Price Target: $11 → $52
Current: $13.23
Upside: +293.05%
Foghorn Therapeutics
Dec 16, 2024
Maintains: Buy
Price Target: $18 → $14
Current: $4.20
Upside: +233.33%
Centessa Pharmaceuticals
Sep 11, 2024
Maintains: Buy
Price Target: $13 → $19
Current: $12.30
Upside: +54.47%
Ascendis Pharma
Aug 13, 2024
Maintains: Buy
Price Target: $174 → $196
Current: $151.46
Upside: +29.41%
Artiva Biotherapeutics
Aug 13, 2024
Initiates: Buy
Price Target: $21
Current: $2.08
Upside: +909.62%
Syndax Pharmaceuticals
Jun 28, 2024
Initiates: Buy
Price Target: $37
Current: $10.70
Upside: +245.79%
ProKidney
Jun 10, 2024
Maintains: Buy
Price Target: $15 → $6
Current: $0.72
Upside: +737.17%
May 20, 2024
Maintains: Buy
Price Target: $35 → $46
Current: $44.23
Upside: +4.00%
Feb 23, 2024
Initiates: Buy
Price Target: $81
Current: $58.98
Upside: +37.33%
Feb 20, 2024
Initiates: Buy
Price Target: $35
Current: $20.15
Upside: +73.70%
Feb 5, 2024
Initiates: Buy
Price Target: $36
Current: $1.19
Upside: +2,925.21%
Nov 11, 2022
Initiates: Buy
Price Target: $16
Current: $38.39
Upside: -58.32%
Aug 15, 2022
Initiates: Buy
Price Target: $40
Current: $30.07
Upside: +33.02%
Aug 15, 2022
Initiates: Buy
Price Target: $20
Current: $4.09
Upside: +389.00%
Aug 3, 2022
Initiates: Buy
Price Target: $8
Current: $2.07
Upside: +286.47%
Mar 4, 2022
Initiates: Buy
Price Target: $27
Current: $0.61
Upside: +4,326.96%
Aug 3, 2021
Initiates: Buy
Price Target: $52
Current: $14.21
Upside: +265.94%
Apr 13, 2021
Initiates: Buy
Price Target: $27
Current: $0.81
Upside: +3,234.16%
Mar 8, 2021
Initiates: Buy
Price Target: $33
Current: $1.60
Upside: +1,962.50%